Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation



Status:Completed
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:April 2014
End Date:January 2016

Use our guide to learn which trials are right for you!

Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation: A Pilot Trial of the "Dynamic Thoracic Impedance Bed Rest Test"

This pilot study proposes to perform measurements of approved thoracic impedance technology
that will help answer questions in patients with decompensated heart failure.

Improved metrics derived from the transthoracic impedance (Z) available from implanted
Medtronic devices may provide more sensitive indicators of the state of compensation for
heart failure patients. Quantification of specific data may provide new information that can
improve quality of life for patients and offer vital information to clinicians regarding the
adequacy of inpatient and outpatient assessment and management of acute decompensated heart
failure.

Inclusion Criteria:

- Patients with systolic dysfunction

- Able to provide informed consent

- Have a Medtronic manufactured device with Thoracic Impendence Monitoring capabilities

Exclusion Criteria:

- Patients with severe congestive heart failure who are intubated

- Patients who are oxygen dependent on continuous positive or bilevel positive
ventilation

- Inability to tolerate postural variations due to congestive heart failure or other
medical or surgical condition.Unable to complete proposed testing

- Subjects who cannot giveWill not give written, informed consent on their own behalf
We found this trial at
1
site
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials